Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Tuberculosis

Free Subscription Articles published in Emerg Infect Dis Retrieve available abstracts of 62 articles: HTML format Text format

Single Articles

November 2019
1. BAFFOE-BONNIE A, Houpt ER, Turner L, Dodge D, et al
   Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis in a Single Patient.
   Emerg Infect Dis. 2019;25.
   PubMed     Text format     Abstract available
   
   
   October 2019
2. SAKHAEE F, Vaziri F, Bahramali G, Taremian K, et al
   Pulmonary Infection Associated with Mycobacterium canariasense in Suspected Tuberculosis Patient, Iran.
   Emerg Infect Dis. 2019;25:1984-1986.
   PubMed     Text format     Abstract available
   
   
   
3. VONNAHME LA, Haddad MB, Navin TR
   Factoring Prior Treatment into Tuberculosis Infection Prevalence Estimates, United States, 2011-2012.
   Emerg Infect Dis. 2019;25:1949-1951.
   PubMed     Text format     Abstract available
   
   
   
4. MURRAY KO, Castillo-Carandang NT, Mandalakas AM, Cruz AT, et al
   Prevalence of Tuberculosis in Children After Natural Disasters, Bohol, Philippines.
   Emerg Infect Dis. 2019;25:1884-1892.
   PubMed     Text format     Abstract available
   
   
   September 2019
5. KUMAR A, Kunoor A, Eapen M, Singh PK, et al
   Blastomycosis Misdiagnosed as Tuberculosis, India.
   Emerg Infect Dis. 2019;25:1776-1777.
   PubMed     Text format     Abstract available
   
   
   July 2019
6. HUANG F, van den Hof S, Qu Y, Li Y, et al
   Added Value of Comprehensive Program to Provide Universal Access to Care for Sputum Smear-Negative Drug-Resistant Tuberculosis, China.
   Emerg Infect Dis. 2019;25:1289-1296.
   PubMed     Text format     Abstract available
   
   
   May 2019
7. MBUAGBAW L, Guglielmetti L, Hewison C, Bakare N, et al
   Outcomes of Bedaquiline Treatment in Patients with Multidrug-Resistant Tuberculosis.
   Emerg Infect Dis. 2019;25:936-943.
   PubMed     Text format     Abstract available
   
   
   
8. PAUDEL S, Nakajima C, Mikota SK, Gairhe KP, et al
   Mixed Mycobacterium tuberculosis Lineage Infection in 2 Elephants, Nepal.
   Emerg Infect Dis. 2019;25:1031-1032.
   PubMed     Text format     Abstract available
   
   
   April 2019
9. CAMPBELL JR, Johnston JC, Cook VJ, Sadatsafavi M, et al
   Cost-effectiveness of Latent Tuberculosis Infection Screening before Immigration to Low-Incidence Countries.
   Emerg Infect Dis. 2019;25:661-671.
   PubMed     Text format     Abstract available
   
   
   March 2019
10. HOLLAND DP, Alexander S, Onwubiko U, Goswami ND, et al
    Response to Isoniazid-Resistant Tuberculosis in Homeless Shelters, Georgia, USA, 2015-2017.
    Emerg Infect Dis. 2019;25:593-595.
    PubMed     Text format     Abstract available
    
    
    
11. LOVEDAY M, Hlangu S, Furin J
    Healthcare Provider Discrimination toward Pregnant Women with Rifampin-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:609-610.
    PubMed     Text format     Abstract available
    
    
    
12. GENESTET C, Tatai C, Berland JL, Claude JB, et al
    Prospective Whole-Genome Sequencing in Tuberculosis Outbreak Investigation, France, 2017-2018.
    Emerg Infect Dis. 2019;25:589-592.
    PubMed     Text format     Abstract available
    
    
    
13. SKIBA Y, Mokrousov I, Nabirova D, Vyazovaya A, et al
    Mycobacterium tuberculosis RD-Rio Strain in Kazakhstan.
    Emerg Infect Dis. 2019;25:604-606.
    PubMed     Text format     Abstract available
    
    
    
14. WANSAULA Z, Wortham JM, Mindra G, Haddad MB, et al
    Bacillus Calmette-Guerin Cases Reported to the National Tuberculosis Surveillance System, United States, 2004-2015.
    Emerg Infect Dis. 2019;25:451-456.
    PubMed     Text format     Abstract available
    
    
    
15. PANG Y, An J, Shu W, Huo F, et al
    Epidemiology of Extrapulmonary Tuberculosis among Inpatients, China, 2008-2017.
    Emerg Infect Dis. 2019;25:457-464.
    PubMed     Text format     Abstract available
    
    
    
16. OSMAN M, Harausz EP, Garcia-Prats AJ, Schaaf HS, et al
    Treatment Outcomes in Global Systematic Review and Patient Meta-Analysis of Children with Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2019;25:441-450.
    PubMed     Text format     Abstract available
    
    
    
17. CRUZ AT, Starke JR
    Window Period Prophylaxis for Children Exposed to Tuberculosis, Houston, Texas, USA, 2007-2017.
    Emerg Infect Dis. 2019;25:523-528.
    PubMed     Text format     Abstract available
    
    
    
18. BAINOMUGISA A, Pandey S, Donnan E, Simpson G, et al
    Cross-Border Movement of Highly Drug-Resistant Mycobacterium tuberculosis from Papua New Guinea to Australia through Torres Strait Protected Zone, 2010-2015.
    Emerg Infect Dis. 2019;25:406-415.
    PubMed     Text format     Abstract available
    
    
    
19. DOMINGUEZ J, Acosta F, Perez-Lago L, Sambrano D, et al
    Simplified Model to Survey Tuberculosis Transmission in Countries Without Systematic Molecular Epidemiology Programs.
    Emerg Infect Dis. 2019;25:507-514.
    PubMed     Text format     Abstract available
    
    
    
20. ARANDJELOVIC I, Merker M, Richter E, Kohl TA, et al
    Longitudinal Outbreak of Multidrug-Resistant Tuberculosis in a Hospital Setting, Serbia.
    Emerg Infect Dis. 2019;25:555-558.
    PubMed     Text format     Abstract available
    
    
    
21. BOUZOUITA I, Cabibbe AM, Trovato A, Daroui H, et al
    Whole-Genome Sequencing of Drug-Resistant Mycobacterium tuberculosis Strains, Tunisia, 2012-2016.
    Emerg Infect Dis. 2019;25:538-546.
    PubMed     Text format     Abstract available
    
    
    
22. LIPWORTH S, Jajou R, de Neeling A, Bradley P, et al
    SNP-IT Tool for Identifying Subspecies and Associated Lineages of Mycobacterium tuberculosis Complex.
    Emerg Infect Dis. 2019;25:482-488.
    PubMed     Text format     Abstract available
    
    
    
23. EL ACHKAR S, Demanche C, Osman M, Rafei R, et al
    Drug-Resistant Tuberculosis, Lebanon, 2016 - 2017.
    Emerg Infect Dis. 2019;25:564-568.
    PubMed     Text format     Abstract available
    
    
    
24. ACOSTA F, Agapito J, Cabibbe AM, Caceres T, et al
    Exportation of MDR TB to Europe from Setting with Actively Transmitted Persistent Strains in Peru.
    Emerg Infect Dis. 2019;25:596-598.
    PubMed     Text format     Abstract available
    
    
    December 2018
25. MILLER MA, Buss P, Parsons SDC, Roos E, et al
    Conservation of White Rhinoceroses Threatened by Bovine Tuberculosis, South Africa, 2016-2017.
    Emerg Infect Dis. 2018;24:2373-2375.
    PubMed     Text format     Abstract available
    
    
    
26. SANTOS N, Nunes T, Fonseca C, Vieira-Pinto M, et al
    Spatial Analysis of Wildlife Tuberculosis Based on a Serologic Survey Using Dried Blood Spots, Portugal.
    Emerg Infect Dis. 2018;24:2169-2175.
    PubMed     Text format     Abstract available
    
    
    November 2018
27. KAYOMO MK, Hasker E, Aloni M, Nkuku L, et al
    Outbreak of Tuberculosis and Multidrug-Resistant Tuberculosis, Mbuji-Mayi Central Prison, Democratic Republic of the Congo.
    Emerg Infect Dis. 2018;24:2029-2035.
    PubMed     Text format     Abstract available
    
    
    
28. NISHIMURA T, Ota M, Mori M, Hasegawa N, et al
    Estimating Latent Tuberculosis Infection Using Interferon-gamma Release Assay, Japan.
    Emerg Infect Dis. 2018;24:2111-2113.
    PubMed     Text format     Abstract available
    
    
    
29. AUNG HL, Nyunt WW, Fong Y, Russell B, et al
    Acquired Resistance to Antituberculosis Drugs.
    Emerg Infect Dis. 2018;24:2134.
    PubMed     Text format    
    
    
    October 2018
30. HADDAD MB, Raz KM, Lash TL, Hill AN, et al
    Simple Estimates for Local Prevalence of Latent Tuberculosis Infection, United States, 2011-2015.
    Emerg Infect Dis. 2018;24:1930-1933.
    PubMed     Text format     Abstract available
    
    
    
31. GARFEIN RS, Liu L, Cuevas-Mota J, Collins K, et al
    Tuberculosis Treatment Monitoring by Video Directly Observed Therapy in 5 Health Districts, California, USA.
    Emerg Infect Dis. 2018;24:1806-1815.
    PubMed     Text format     Abstract available
    
    
    June 2018
32. MICHELET L, De Cruz K, Henault S, Tambosco J, et al
    Mycobacterium bovis Infection of Red Fox, France.
    Emerg Infect Dis. 2018;24:1150-1153.
    PubMed     Text format     Abstract available
    
    
    
33. SANTIN M, Barrabeig I, Malchair P, Gonzalez-Luquero L, et al
    Pulmonary Infections with Nontuberculous Mycobacteria, Catalonia, Spain, 1994-2014.
    Emerg Infect Dis. 2018;24:1091-1094.
    PubMed     Text format     Abstract available
    
    
    March 2018
34. NGUYEN DT, Teeter LD, Graves J, Graviss EA, et al
    Characteristics Associated with Negative Interferon-gamma Release Assay Results in Culture-Confirmed Tuberculosis Patients, Texas, USA, 2013-2015.
    Emerg Infect Dis. 2018;24:534-540.
    PubMed     Text format     Abstract available
    
    
    
35. CHERNYAEVA E, Rotkevich M, Krasheninnikova K, Yurchenko A, et al
    Whole-Genome Analysis of Mycobacterium tuberculosis from Patients with Tuberculous Spondylitis, Russia.
    Emerg Infect Dis. 2018;24:579-583.
    PubMed     Text format     Abstract available
    
    
    
36. ALTHOMSONS SP, Hill AN, Harrist AV, France AM, et al
    Statistical Method to Detect Tuberculosis Outbreaks among Endemic Clusters in a Low-Incidence Setting.
    Emerg Infect Dis. 2018;24:573-575.
    PubMed     Text format     Abstract available
    
    
    
37. RANDO-SEGURA A, Aznar ML, Moreno MM, Espasa M, et al
    Drug Resistance of Mycobacterium tuberculosis Complex in a Rural Setting, Angola.
    Emerg Infect Dis. 2018;24:569-572.
    PubMed     Text format     Abstract available
    
    
    
38. BRENT AJ, Nyundo C, Langat J, Mulunda C, et al
    Prospective Observational Study of Incidence and Preventable Burden of Childhood Tuberculosis, Kenya.
    Emerg Infect Dis. 2018;24:514-523.
    PubMed     Text format    
    
    
    
39. NAIK PR, Moonan PK, Nirgude AS, Shewade HD, et al
    Use of Verbal Autopsy to Determine Underlying Cause of Death during Treatment of Multidrug-Resistant Tuberculosis, India.
    Emerg Infect Dis. 2018;24:478-484.
    PubMed     Text format     Abstract available
    
    
    
40. YEN YF, Pan SW, Su VY, Chuang PH, et al
    Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan(1).
    Emerg Infect Dis. 2018;24:498-505.
    PubMed     Text format     Abstract available
    
    
    
41. KLOTZ D, Barth SA, Baumgartner W, Hewicker-Trautwein M, et al
    Mycobacterium avium subsp. hominissuis Infection in a Domestic Rabbit, Germany.
    Emerg Infect Dis. 2018;24:596-598.
    PubMed     Text format     Abstract available
    
    
    
42. LOUTET MG, Davidson JA, Brown T, Dedicoat M, et al
    Acquired Resistance to Antituberculosis Drugs in England, Wales, and Northern Ireland, 2000-2015.
    Emerg Infect Dis. 2018;24:524-533.
    PubMed     Text format     Abstract available
    
    
    November 2017
43. NATHAVITHARANA RR, Shi CX, Chindelevitch L, Calderon R, et al
    Polyclonal Pulmonary Tuberculosis Infections and Risk for Multidrug Resistance, Lima, Peru.
    Emerg Infect Dis. 2017;23:1887-1890.
    PubMed     Text format     Abstract available
    
    
    
44. TAO NN, He XC, Zhang XX, Liu Y, et al
    Drug-Resistant Tuberculosis among Children, China, 2006-2015.
    Emerg Infect Dis. 2017;23:1800-1805.
    PubMed     Text format     Abstract available
    
    
    October 2017
45. ACHAR J, Hewison C, Cavalheiro AP, Skrahina A, et al
    Off-Label Use of Bedaquiline in Children and Adolescents with Multidrug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    
46. MARYANDYSHEV A, Pontali E, Tiberi S, Akkerman O, et al
    Bedaquiline and Delamanid Combination Treatment of 5 Patients with Pulmonary Extensively Drug-Resistant Tuberculosis.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    
47. JASPARD M, Elefant-Amoura E, Melonio I, De Montgolfier I, et al
    Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    March 2017
48. SETO J, Wada T, Suzuki Y, Ikeda T, et al
    Mycobacterium tuberculosis Transmission among Elderly Persons, Yamagata Prefecture, Japan, 2009-2015.
    Emerg Infect Dis. 2017;23:448-455.
    PubMed     Text format     Abstract available
    
    
    
49. MALM S, Linguissi LS, Tekwu EM, Vouvoungui JC, et al
    New Mycobacterium tuberculosis Complex Sublineage, Brazzaville, Congo.
    Emerg Infect Dis. 2017;23:423-429.
    PubMed     Text format     Abstract available
    
    
    
50. ADJEMIAN J, Frankland TB, Daida YG, Honda JR, et al
    Epidemiology of Nontuberculous Mycobacterial Lung Disease and Tuberculosis, Hawaii, USA.
    Emerg Infect Dis. 2017;23:439-447.
    PubMed     Text format     Abstract available
    
    
    
51. SCOTT C, Cavanaugh JS, Silk BJ, Ershova J, et al
    Comparison of Sputum-Culture Conversion for Mycobacterium bovis and M. tuberculosis.
    Emerg Infect Dis. 2017;23:456-462.
    PubMed     Text format     Abstract available
    
    
    
52. BOURDILLON PM, Goncalves CC, Pelissari DM, Arakaki-Sanchez D, et al
    Increase in Tuberculosis Cases among Prisoners, Brazil, 2009-20141.
    Emerg Infect Dis. 2017;23:496-499.
    PubMed     Text format     Abstract available
    
    
    
53. SIMPSON G, Zimmerman R, Shashkina E, Chen L, et al
    Mycobacterium tuberculosis Infection among Asian Elephants in Captivity.
    Emerg Infect Dis. 2017;23:513-516.
    PubMed     Text format     Abstract available
    
    
    
54. CHANDRANAIK BM, Shivashankar BP, Umashankar KS, Nandini P, et al
    Mycobacterium tuberculosis Infection in Free-Roaming Wild Asian Elephant.
    Emerg Infect Dis. 2017;23:555-557.
    PubMed     Text format     Abstract available
    
    
    
55. BENOIT SR, Gregg EW, Jonnalagadda S, Phares CR, et al
    Association of Diabetes and Tuberculosis Disease among US-Bound Adult Refugees, 2009-2014.
    Emerg Infect Dis. 2017;23:543-545.
    PubMed     Text format     Abstract available
    
    
    
56. ALLANA S, Shashkina E, Mathema B, Bablishvili N, et al
    pncA Gene Mutations Associated with Pyrazinamide Resistance in Drug-Resistant Tuberculosis, South Africa and Georgia.
    Emerg Infect Dis. 2017;23:491-495.
    PubMed     Text format     Abstract available
    
    
    
57. ZACHARIAH A, Pandiyan J, Madhavilatha GK, Mundayoor S, et al
    Mycobacterium tuberculosis in Wild Asian Elephants, Southern India.
    Emerg Infect Dis. 2017;23:504-506.
    PubMed     Text format     Abstract available
    
    
    
58. MILLER MA, Buss PE, van Helden PD, Parsons SD, et al
    Mycobacterium bovis in a Free-Ranging Black Rhinoceros, Kruger National Park, South Africa, 2016.
    Emerg Infect Dis. 2017;23:557-558.
    PubMed     Text format     Abstract available
    
    
    
59. DAVIDSON JA, Loutet MG, O'Connor C, Kearns C, et al
    Epidemiology of Mycobacterium bovis Disease in Humans in England, Wales, and Northern Ireland, 2002-2014.
    Emerg Infect Dis. 2017;23:377-386.
    PubMed     Text format     Abstract available
    
    
    
60. SURIE D, Fane O, Finlay A, Ogopotse M, et al
    Molecular, Spatial, and Field Epidemiology Suggesting TB Transmission in Community, Not Hospital, Gaborone, Botswana.
    Emerg Infect Dis. 2017;23:487-490.
    PubMed     Text format     Abstract available
    
    
    February 2017
61. DENNING DW, Perlin DS, Muldoon EG, Colombo AL, et al
    Delivering on Antimicrobial Resistance Agenda Not Possible without Improving Fungal Diagnostic Capabilities.
    Emerg Infect Dis. 2017;23.
    PubMed     Text format     Abstract available
    
    
    December 2016
62. BARASONA JA, Acevedo P, Diez-Delgado I, Queiros J, et al
    Tuberculosis-Associated Death among Adult Wild Boars, Spain, 2009-2014.
    Emerg Infect Dis. 2016;22:2178-2180.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: